Neuronostics is a software biomarker company for epilepsy, using EEG and mathematical modeling to quantify seizure risk and diagnostic likelihood. It is differentiated by its modeling depth, though ultimate adoption depends on whether outputs improve decision-making beyond expert interpretation.